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The  identiﬁcation  of key  “driver”  groups  in  inﬂuenza  epidemics  is of much  interest  for  the  implementation
of  effective  public  health  response  strategies,  including  vaccination  programs.  However,  the  relative
importance  of  different  age groups  in  propagating  epidemics  is  uncertain.
During a communicable  disease  outbreak,  some  groups  may  be disproportionately  represented  during
the outbreak’s  ascent  due  to increased  susceptibility  and/or  contact  rates.  Such  groups  or subpopulations
can  be identiﬁed  by  considering  the  proportion  of cases  within  the  subpopulation  occurring  before  (Bp)
and  after  the  epidemic  peak  (Ap)  to calculate  the subpopulation’s  relative  risk,  RR  =Bp/Ap.  We  estimated
RR  for  several  subpopulations  (age groups)  using  data  on  laboratory-conﬁrmed  US  inﬂuenza  hospitaliza-
tions  during  epidemics  between  2009  and  2014.  Additionally,  we simulated  various  inﬂuenza  outbreaks
in  an  age-stratiﬁed  population,  relating  the  RR  to the  impact  of vaccination  in each  subpopulation  on  the
epidemic’s  initial  effective  reproductive  number  Re(0).
We  found  that  children  aged  5–17  had  the  highest  estimates  of RR  during  the  ﬁve largest  inﬂuenza  A
outbreaks,  though  the  relative  magnitude  of  RR in  this  age group  compared  to other  age  groups  varied,
being  highest  for the  2009  A/H1N1  pandemic.  For  the  2010–2011  and  2012–2013  inﬂuenza  B epidemics,
adults  aged  18–49,  and  0–4 year-olds  had  the  highest  estimates  of RR,  respectively.
For 83%  of simulated  epidemics,  the group  with  the  highest  RR was  also  the  group  for  which  initial
distribution  of  a given  quantity  of  vaccine  would  result  in  the largest  reduction  of  Re(0).  In the largest  40%
of  simulated  outbreaks,  the  group  with  the  highest  RR  and  the largest  vaccination  impact  was  children
5–17.
While  the  relative  importance  of different  age  groups  in propagating  inﬂuenza  outbreaks  varies,  chil-
dren  aged  5–17  play  the  leading  role  during  the largest  inﬂuenza  A epidemics.  Extra  vaccination  efforts
for  this  group  may  contribute  to reducing  the  epidemic’s  impact  in the  whole  community.
©  2015  The  Authors.  Published  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-ND. Introduction
The relative importance of different age cohorts in driving
nﬂuenza epidemics is not fully understood. One reason for this
s the lack of consensus on what makes an age group “impor-
ant” in transmission, and how this should be quantiﬁed. School
ge children (aged 5–17) were found to have experienced the
ighest inﬂuenza attack rate during the 2009 A/H1N1 pandemic
Reed et al., 2012), as well as during certain inﬂuenza seasons prior
o the pandemic (Monto et al., 1985), though for other seasons,
∗ Corresponding author. Tel.: +1 6174321361.
E-mail address: cworby@hsph.harvard.edu (C.J. Worby).
ttp://dx.doi.org/10.1016/j.epidem.2015.04.003
755-4365/© 2015 The Authors. Published by Elsevier B.V. This is an open access article 
/).license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
age-speciﬁc attack rates for inﬂuenza A infection were relatively
similar for different age groups (Monto and Kioumehr, 1975).
Studies have shown that inﬂuenza transmission decreases during
school closure periods (Cauchemez et al., 2008) and increases when
schools are opened (Huang et al., 2014), suggesting the importance
of schoolchildren in propagating inﬂuenza. However, estimates of
the magnitude of change in transmission dynamics of inﬂuenza
during time periods when schools are open vs. periods when they
are closed are variable (Jackson et al., 2013a; Flasche et al., 2011).
Studies based on transmission modeling have also suggested the
key role of school age children in driving inﬂuenza epidemics (Basta
et al., 2009; Wallinga et al., 2006). However, conclusions of those
studies hinge on certain assumptions behind transmission mod-
els that are rarely calibrated against data from speciﬁc inﬂuenza
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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easons, particularly in the non-pandemic context. For example,
n age-stratiﬁed transmission models, distribution of individual
usceptibility to infection within each age stratum is one aspect
hat received very little attention in the literature. Earlier peaks of
nﬂuenza epidemics in younger age groups have been documented,
ut their interpretation has been controversial. In one study (Olson
t al., 2007), they were cited as evidence of the importance of these
roups in transmission, yet it has been argued on the contrary
Schanzer et al., 2011) that small magnitude of the differences in
eak times in different age groups “casts doubt on the hypothesis
hat younger school-age children actually lead inﬂuenza epidemic
aves”. One could further counter that assertion, suggesting that
ransmission in different age groups is strongly interconnected,
eading to so-called “slaved” dynamics in which incidence grows
t a similar rate in all age groups (Keeling and Rohani, 2008). In
his scenario, the peak incidence in the driver groups – that is,
roups for which depletion of susceptibles has the largest rela-
ive impact on the epidemic’s reproductive number (Wallinga et al.,
010; Goldstein et al., 2010) – corresponds with peak incidence in
he community.
In previous work (Wallinga et al., 2010) we deﬁned a measure
f the importance of a particular age (or other demographic) group
s follows: importance in transmission is proportional to the (neg-
tive) change in the epidemic’s effective reproductive number that
ould result from successfully immunizing a small, ﬁxed num-
er of persons randomly chosen from within this group. While
his deﬁnition is clearly relevant to vaccination policies (vacci-
ating the most “important” groups yields the highest impact on
he epidemic’s dynamics in the whole community), estimating the
otential impact of vaccination for a particular epidemic is quite
ifﬁcult due to a variety of data limitations. Here, we hypothe-
ized that a simple, heuristic but precisely deﬁned measure that
s readily estimated for each age group from age-stratiﬁed epi-
emiologic data would be highly predictive of importance deﬁned
bove, and that it should in general be possible to estimate rela-
ive importance of different groups in driving transmission of an
nfection even when probabilities of case-reporting vary system-
tically across groups, a common feature in surveillance data. This
easure, which for inﬂuenza can be estimated separately for each
f the circulating (sub) types, A/H1, A/H3 and B, is a simple relative
isk (RR) of cases in a particular age group before the peak of the
pidemic compared to after the peak of the epidemic. The rationale
or this choice is the idea that the key age groups in transmission
ill experience a disproportionate depletion of susceptible indi-
iduals (attack rates) relative to the whole population during the
scent stages of inﬂuenza epidemics. This would translate into a
ower proportion of such age groups in overall inﬂuenza incidence
or other inﬂuenza-associated outcomes that can be measured from
ata) during the descent stages of epidemics.
Estimating incidence of inﬂuenza infections in different age
roups before and after the epidemic peak is challenging with
he available data. At the same time, our proposed summary
tatistic RR requires only the relative change in such incidence
efore vs. after the epidemic peak. This relative change can be
ssessed by considering the corresponding relative change for a
urrogate measure (proxy) of inﬂuenza incidence. Such a proxy
ould need to represent a ﬁxed (but not necessarily high) pro-
ortion of the true incidence during those periods (Supporting
nformation). This requires high speciﬁcity,  which, for example, pre-
ludes the ILI data stream from serving as such proxy because
he frequency of other conditions causing a nonspeciﬁc diagnosis
ike ILI will change through the season. It does not require high
ensitivity, only time-invariant (or more precisely, equally time-
arying) sensitivity for each age group. In our analysis, such a
roxy is provided by laboratory-conﬁrmed, (sub)typed inﬂuenza
ospitalizations in the Inﬂuenza Surveillance Hospitalizationcs 13 (2015) 10–16 11
Network (FluSurv-NET). Importantly, interpreting this statistic
does not require prior knowledge of either the overall or the group-
dependent reporting rate (in this instance, case-hospitalization
rate). This means that when laboratory-conﬁrmed hospitalizations,
representing only a small, age-speciﬁc fraction of all incident cases,
are used as a surrogate measure of infections for the estimation
of RR, it will estimate the importance of particular age groups in
transmitting infection.
Here we report the estimation of the RR from data on
laboratory-conﬁrmed US inﬂuenza hospitalizations during epi-
demics associated with inﬂuenza A/H1N1, A/H3N2 and B between
2009 and 2014. This recent period is particularly interesting as
inﬂuenza vaccination coverage rates have increased following the
2009 pandemic, at least in the US, potentially resulting in different
distributions of susceptibility compared to what has taken place
in the pre-pandemic period, and the impact of that on the relative
roles of the different age groups has not been assessed in detail in
the literature. We then go on to test the hypothesis that the group
identiﬁed as most important by the RR statistic is predictably the
one with the highest importance by our deﬁnition—the group for
which immunization of a ﬁxed number of persons would cause
the greatest reduction in the reproduction number of the epidemic
in the population as a whole. In order to investigate this corre-
spondence, we  simulated inﬂuenza epidemics in an age-stratiﬁed
population with contact rates between the age groups borrowed
from the POLYMOD study (Mossong et al., 2008) and explored a
variety of scenarios for the relative susceptibility to infection for the
different age groups to reﬂect the diversity of inﬂuenza epidemics.
2. Materials and methods
2.1. Data
We used the Inﬂuenza Surveillance Hospitalization Network
(FluSurv-NET) data for the 2009 pandemic and the 2010–2011
through 2012–2013 inﬂuenza seasons collected between October
and April (with no data on sub-typing of inﬂuenza A hos-
pitalizations available prior to 2009). This network conducted
population-based inﬂuenza-associated hospitalization surveil-
lance in over 80 selected counties located in California, Colorado,
Connecticut, Georgia, Idaho, Maryland, Michigan, Minnesota, New
York, Oklahoma, Ohio, Oregon, Rhode Island, Tennessee and Utah.
The surveillance area encompassed a total of 276 reporting hospi-
tals serving over 29 million children and adults and representing
about 9% of the US population. Laboratory testing for inﬂuenza
was ordered at the discretion of clinicians providing clinical care.
Laboratory conﬁrmation was  deﬁned as a positive result from
viral culture, direct or indirect ﬂuorescent antibody staining, rapid
antigen test, or reverse transcription polymerase chain reaction
(rt-PCR). Aggregate hospitalization counts were used in the study.
This activity was determined to be routine public health surveil-
lance by the US Centers for Disease Control and Prevention and by
state and local institutional review boards and no informed consent
from the participants was  sought. This study, based on the analy-
sis of aggregated existing data, was determined to be not “Human
Subjects Research”.
2.2. Hospitalization data analysis
For each season and inﬂuenza (sub)type, we  determine the
periods before and after the peak of that (sub)type’s epidemic
as follows: For each age group g g = (1, . . .,  5) and week t, let
X1gt , X3
g
t , XB
g
t be the counts for the number of conﬁrmed hospi-
talizations in that group on that week with the (sub)types A/H1N1,
A/H3N2, and B, respectively, and XAgt be the number of un-subtyped
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nﬂuenza A hospitalizations. We  estimate the number of hospital-
zations due to inﬂuenza A/H1N1 in a group g on week t as
1gt = X1gt + XAgt ×
X1gt(
X1gt + X3gt
) (1)
ith a similar correction for A/H3N2. For inﬂuenza B, HBtg = XBtg . To
stimate the epidemic’s ascent and descent periods we address the
otentially disproportionate impact of the elderly (aged 65+) on
ospitalizations compared to their share in incidence by looking
t the peak of the weekly hospitalizations among the four non-
lderly age groups, deﬁning the before and after the peak periods
orrespondingly. The total number of non-elderly hospitalizations
or (sub)type S on week t is
SNEt =
4∑
g=1
HSgt (S = 1, 2, B)
The peak week for each subtype is deﬁned as the week tp for
hich HSNEt is maximal. To account for the uncertainty of the peak
eek due to noise in the data, and to avoid misclassiﬁcation of
ounts as before or after-the-peak, we excluded weeks tp − 1 and
p + 1, and deﬁne the period before the peak to be weeks up to tp − 2
inclusive), and the period after the peak are weeks starting tp + 2.
The estimation of RR (described below for an inﬂuenza A
sub)type) is performed as follows. We  assume that the actual num-
er of infected cases in each age group due to each subtype is large,
nd the probability of resulting in a conﬁrmed hospitalization is
mall, with the number of detected hospitalizations well approxi-
ated by a Poisson variable. Moreover for each hospitalization in
able 1
eak week for A/H1N1 hospitalizations, and the relative risk for being in a given age group
eriod.
Relative risks (RR) in different age groups for periods before vs. after the epidemic peak
Season Peak week Aged 0–4 Aged 5–17 
RR 95% CIa RR 95% CI 
2009 42 1.06 0.91, 1.23 1.84 1.58, 2.14 
2010–2011 8 1.22 0.80, 1.84 1.37 0.74, 2.45 
2011–2012 13 3.03 0.89, 9.53 1.21 0.47, 2.91 
2013–2014 2 1.26 1.03, 1.52 1.31 1.00, 1.68 
a CI: conﬁdence interval.
able 2
eak week for A/H3N2 hospitalizations, and the relative risk for being in a given age group
eriod.
Relative risks (RR) in different age groups for periods before vs. after the epidemic peak
Season Peak week Aged 0–4 Aged 5–17 
RR 95% CIa RR 95% CI 
2010–2011 8 1.44 1.08, 1.90 1.83 1.07, 3.05 
2011–2012 12 1.29 0.87, 1.86 1.63 0.87, 2.92 
2012–2013 1 1.22 1.01, 1.46 1.86 1.41, 2.40 
a CI: conﬁdence interval.
able 3
eak week for inﬂuenza B hospitalizations, and the relative risk for being in a given a
fter-the-peak period.
Relative risks (RR) in different age groups for periods before vs. after the epidemic peak
Season Peak week Aged 0–4 Aged 5–17 
RR 95% CIa RR 95% CI 
2010–2011 8 1.00 0.78, 1.25 0.99 0.70, 1.35 
2012–2013 8 1.32 1.08, 1.61 0.97 0.78, 1.21 
a CI: conﬁdence interval.cs 13 (2015) 10–16
the surveillance system in the chosen age group, there is a proba-
bility pg for this hospitalization to be subtyped, and we assume that
this probability is the same for both inﬂuenza A subtypes (further
details in Section 4). The observed counts for the number of hospi-
talizations in a group g due to the chosen inﬂuenza A subtype, the
other subtype and the un-subtyped ones are therefore independent
and Poisson distributed with means
(
g1, 
g
2, 
g
3
)
=
(
gX × pg, 
g
Y × pg,
(
gX + 
g
Y
)
×
(
1 − pg
))
here gX, 
g
Y are the Poisson parameters, proportional to incidence
rates due to the chosen subtype and the other subtype in the age
group g. The estimation for gX, 
g
Y is performed in a Bayesian frame-
work, with posterior samples for those parameters for the periods
before and after the epidemic peak in different age groups used to
produce a posterior sample of estimates of RR for each age group for
which the mean and the 95% credible interval are reported. More
details are provided in the Supporting Information. We  note here
that the point estimates on RR obtained (Tables 1–3) are virtually
identical to the “intuitive” estimate one would get using the hospi-
talization rates given by Eq. (1). The purpose of this more elaborate
procedure is to produce appropriate uncertainty estimates for the
composite parameters of interest. We  also note (see Supporting
information) that the relative magnitudes of the RR estimates for
the different age groups are independent of (the age-speciﬁc) case
hospitalization rates.2.3. Simulations
We  simulated inﬂuenza outbreaks in a stratiﬁed population
with 5 age groups (0–4, 5–17, 18–49, 50–64, 65+). Transmission
 among A/H1N1 hospitalizations for the before-the-peak period vs. after-the-peak
 for inﬂuenza A/H1N1
Aged 18–49 Aged 50–64 Aged 65+
RR 95% CI RR 95% CI RR 95% CI
1.02 0.94, 1.11 0.67 0.58, 0.77 0.67 0.54, 0.82
1.28 1.05, 1.58 0.75 0.60, 0.93 0.74 0.46, 1.13
1.62 0.97, 2.74 0.81 0.48, 1.36 0.39 0.18, 0.76
1.23 1.13, 1.34 0.86 0.79, 0.94 0.81 0.72, 0.90
 among A/H3N2 hospitalizations for the before-the-peak period vs. after-the-peak
 for inﬂuenza A/H3N2
Aged 18–49 Aged 50–64 Aged 65+
RR 95% CI RR 95% CI RR 95% CI
1.64 1.28, 2.10 1.10 0.86, 1.40 0.74 0.68, 0.81
0.88 0.63, 1.19 1.06 0.76, 1.46 0.94 0.83, 1.07
1.47 1.30, 1.66 1.21 1.07, 1.37 0.75 0.71, 0.80
ge group among inﬂuenza B hospitalizations for the before-the-peak period vs.
 for inﬂuenza B
Aged 18–49 Aged 50–64 Aged 65+
RR 95% CI RR 95% CI RR 95% CI
1.43 1.09, 1.85 1.21 0.82, 1.76 0.69 0.54, 0.87
0.84 0.69, 0.99 0.99 0.82, 1.18 1.00 0.88, 1.13
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ynamics is modeled in the stratiﬁed mass action SIR framework.
ontacts between the different age groups (strata) are described
y a symmetric matrix C = (cij), where cij is the average number
f contacts per unit of time (day) between a pair of individuals in
trata i and j. We  estimate the matrix C using the POLYMOD study
ata (Mossong et al., 2008), averaging out the estimates for eight
uropean countries. Additionally, for each age group i, we  have
. Population size ni (extracted from http://wonder.cdc.gov/
Bridged-Race-v2013.HTML)
. Time-varying number of susceptible individuals hi(t), with
hi = hi(0) being the initial number of susceptibles.
. Individual relative susceptibility si ≤ 1 (per contact with an
infected individual) for each susceptible individual in stratum
i (with si = 1 indicating the maximal possible susceptibility).
Based on previous work (Goldstein et al., 2011), we  assume that
nfectivity is age-independent. The rate of infection between an
nfected individual in stratum j and all of stratum i at time t is then
ij(t) =  × si × hi(t) × cij (2)
with the constant  ﬁxed as described below. The natural history
f inﬂuenza is assumed to have an exponential distribution for the
erial interval with a mean of 2.6 days (Cauchemez et al., 2009). As
uch, the initial next generation matrix is
Nij
)
= 2.6 ×
(
Mij (0)
)
(3)
nd its leading eigenvalue is the initial effective reproductive num-
er Re(0).
The average initial susceptibility in age group i is s¯i = si×hini . We
onsider three possibilities for the distribution of susceptibility in
ach age group:
SD1. Uniform: s¯i = si. Everyone in stratum i is equally susceptible
with susceptibility si.
SD2. All-or-nothing: si = 1. A fraction
hi
ni
of individuals in stratum
i is fully susceptible, the rest have zero susceptibility.
SD3. Balanced si =
√
s¯i. This is an intermediate scenario between
SD1 and SD2 where a fraction hini =
√
s¯i of individuals in stratum
i has susceptibility si =
√
s¯i, the rest have zero susceptibility.
We  present the results for the intermediate scenario SD3 in the
ain body of the text, with the results for distributions SD1 and
D2 deferred to the Supporting Information.
Results of the hospitalizations data analysis suggest that the
ighest estimate of RR for the different epidemics belongs to one the
rst three age groups (0–4, 5–17, 18–49), while the lowest estimate
both on average, as well as for all inﬂuenza A epidemics) belongs to
he elderly (aged 65+), followed by individuals aged 50–64. Moti-
ated by those results, we consider the following 53 = 125 scenarios
or the average initial susceptibilities in the different age groups:
i¯ = 0.5, 0.6, 0.7, 0.8, 0.9 for i ≤ 3;
s¯4 = 0.6; s¯5 = 0.45 (4)
We  ﬁx  in Eq. (2) so that Re(0) = 1.35 when s¯1 = s¯2 = s¯3 = 0.9
the largest possible Re(0) corresponding to the largest allowed
verage initial susceptibilities). Any scenario given by Eq. (4) in
hich the epidemic doesn’t take off (Re(0) ≤ 1) is ignored. Other-
ise, we compute the relative risks RRi for cases during the ascent
s. descent stages of the simulated outbreak for each age group i.
dditionally, we compute, for each age group i, the relative reduc-
ion of the value of the initial effective reproductive number Re(0)
f vaccine of quantity q equaling 2% of the US population is givencs 13 (2015) 10–16 13
entirely to group i. In the main body of the text we present those
results for a perfect vaccine (offering complete protection of the
vaccinated individual). While that does not reﬂect the reality of
inﬂuenza vaccination, perfect vaccine amounts to removing indi-
viduals from the transmission process, and the group for which
a ﬁxed quantity of a perfect vaccine has the largest impact on
Re(0) can be thought of as having the largest relative impact on
propagating the epidemic during its initial stages. In the Suppor-
ting information, we exhibit the corresponding results for a leaky
vaccine whose efﬁcacy (reduction in the susceptibility of each vac-
cinated individual) is assumed to be 60% for the non-elderly and
50% for the elderly (those numbers reﬂect the average estimates of
vaccine efﬁcacy for inﬂuenza A and B epidemics during the recent
years).
3. Results
3.1. Hospitalization data: Identifying the age group with the
highest RR by inﬂuenza (sub)type and year
Tables 1–3 give estimates for RR for various age groups,
inﬂuenza (sub)types and seasons. Combinations of season/
(sub)type for which hospitalization counts had been very low
were excluded from the analysis. For epidemics associated with
inﬂuenza A subtypes, children 5–17 had the highest estimates of
RR among all age groups for the ﬁve largest epidemics during
the time period under study (as assessed by combining data on
inﬂuenza-like illness consultations with data on the percentages of
respiratory specimens testing positive for a particular (sub)type,
http://www.cdc.gov/ﬂu/weekly/pastreports.htm): 2009 A/H1N1,
2012–2013 A/H3N2, 2013–2014 A/H1N1, 2010–2011 A/H3N2 and
the 2010–2011 A/H1N1 epidemics. Adults aged 50–64 and 65+ had
the lowest estimates of RR except for the small, 2011–2012 A/H3N2
epidemic. For inﬂuenza B outbreaks, children 0–4 had the highest
estimate of RR (1.32 (1.08, 1.61)) during the 2012–2013 epidemic,
while adults 18–49 had the highest RR during the 2010–2011 epi-
demic (RR = 1.43 (1.09, 1.85)).
3.2. Simulations
The results of simulations described in Section 2 for the balanced
susceptibility distribution SD3 are displayed in Fig. 1. The symbol
in each square indicates whether the group with the highest RR
and the group for which distribution of a perfect vaccine would
have the largest impact on Re(0) are both children 5–17, or both
children 0–4, or are different from one another. Tables S1–S3 in
the Supplementary Information provide the numerical estimates
of RR and reduction in Re(0) for each group under each scenario.
Results for susceptibility distributions SD1 and SD2 were similar,
and are provided in the Supporting information (Figs. S1 and S2,
Tables S4–S9).
Among the different scenarios involving varying susceptibility
distributions and levels of susceptibility in the younger age groups
(0–4, 5–17, 18–49) a total of 255 epidemics took off (Re(0) > 1).
For 233 (91%) of those epidemics, children 5–17 had the highest
RR. For 214 (84%) of those epidemics, the group with the highest
RR was  also the group for which distribution of a perfect vaccine
(offering complete protection to a vaccinated individual) quantity
equaling 2% of the US population would have the highest impact
on the reduction of Re(0); for a leaky vaccine (partial protection to
every vaccinated individual, with his/her susceptibility reduced by
a given fraction), this number reduced slightly to 211 (83%) epi-
demics (Tables S10–S18). Additionally, for both the perfect and
the leaky vaccine allocations, children aged 5–17 were the group
with both the highest RR and the largest impact on reducing Re(0)
14 C.J. Worby et al. / Epidemics 13 (2015) 10–16
Fig. 1. Simulated epidemics for a range of susceptibility proﬁles described by Eq. (4) for susceptibility distribution SD3. For each of the 125 simulated scenarios, the shaded
c  the h
l t from
t
R
s
4
d
g
t
t
t
c
p
W
p
t
u
g
t
d
a
d
C
i
p
dolor  indicates the initial Re(0) value, while symbols denote whether the group with
argest  impact on Re(0) are both children 5–17, or both children 0–4, or are differen
hrough vaccination for each of the 100 epidemics with the largest
e(0), as well as for all epidemics where 5–17 year-olds had relative
usceptibility ≥0.8.
. Discussion
The relative impact of different age groups on inﬂuenza epi-
emics is not fully understood; indeed, like the notion of “core
roup” in the epidemiology of sexually transmitted infections,
here is no precise and widely agreed upon deﬁnition of the impor-
ance of an age group in transmission of inﬂuenza. Furthermore,
he relative impact may  vary by season, inﬂuenza (sub)type, vac-
ination coverage and other factors. There is no consensus among
revious studies into children’s role in driving inﬂuenza epidemics.
e hypothesized that the RR summary statistic, a heuristic but
recisely deﬁned measure, could reliably identify the age group
hat plays the largest relative role in transmission during a partic-
lar epidemic. This hypothesis revolves around the following idea:
roups that experienced a disproportionate depletion of suscep-
ibles due to inﬂuenza infection relative to the whole population
uring the epidemics’ ascent would have their proportion in over-
ll incidence (or any other inﬂuenza-associated outcomes) decline
uring the epidemics’ descent compared to the ascent period.
hange in a group’s representation over the course of the epidemic
s captured by the summary statistic RR, which is the ratio of its
roportion among cases during the epidemic’s ascent to that in the
escent. A key utility of this statistic lies in the fact that it can beighest RR and the group for which distribution of a perfect vaccine would have the
 one another; absence of a symbol suggests that the epidemic hasn’t taken off.
readily measured from the appropriate epidemic data (in our case,
data on inﬂuenza-conﬁrmed hospitalizations) serving as surrogate
measure for the age-speciﬁc inﬂuenza incidence; the latter being
generally difﬁcult to estimate. Moreover, even if groups differ in the
proportion of incident cases of inﬂuenza infection that enter the
data set (e.g. the proportion of cases hospitalized), the ordering of
groups by RR will reﬂect the ordering of the proportional change in
infection incidence in these groups (see Supporting information).
Here we estimate RR for the 2009–2014 US data on laboratory-
conﬁrmed inﬂuenza hospitalizations for epidemics associated with
the major inﬂuenza (sub)types: A/H1N1, A/H3N2 and B.
For epidemics associated with inﬂuenza A subtypes, our analy-
sis indicates that except for the small 2011–2012 season, children
aged 5–17 had the highest estimated RR among all age groups
while adults aged 50–64 and 65+ had the smallest RR estimates.
Those results are related to the notion supported by several studies
(Basta et al., 2009; Longini et al., 2004; Loeb et al., 2010; Reichert
et al., 2001) that attaining high vaccination rates among children
can have a major impact on mitigation of an inﬂuenza epidemic
in the whole community. Our results also suggest that the impor-
tance of targeting mitigation efforts to the older adults increases
during an epidemic’s decline stage compared to the ascent stage
(Goldstein et al., 2012).For the inﬂuenza B epidemics, children aged 0–4 had the highest
estimated RR among all age groups during the 2012–2013 epi-
demic, while adults aged 18–49 had the highest estimated RR
during the 2010–2011 epidemic. This is likely indicative of an
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ncreased relative susceptibility of those age groups to the corre-
ponding inﬂuenza B strains in those seasons and suggests potential
ifferences in driver groups for inﬂuenza B vs. inﬂuenza A.
For epidemics associated with inﬂuenza A/H1N1, the role of
chool-age children decreased signiﬁcantly in the post-pandemic
eriod compared to the pandemic itself, presumably due to the
mmunity acquired during the pandemic when attack rates among
–17 year-olds were very high (Reed et al., 2012). Moreover in the
ost-pandemic period, the role of 5–17 year olds as drivers of H1N1
pidemics is of less magnitude than the role 5–17 years olds as
rivers of H3N2 epidemics. Compared to the 2010–2011 A/H1N1
eason, the moderately severe 2013–2014 A/H1N1 outbreak saw
n increase in the role of children aged 0–4, presumably due to the
imited immunity to this virus in that age group relative to other
ge groups.
In order to explore to what extent a higher value of RR in the
ospitalization data is indicative of a driver role in an inﬂuenza
pidemic for a particular age group, and what potential impact
ncreased vaccination efforts in a group with a high RR would have
n the dynamics of inﬂuenza transmission in the population, we
erformed a variety of simulations of inﬂuenza transmission in the
ommunity. We  found a strong correspondence between the group
ith the highest value of RR in the simulated data and the group for
hich distributing a small, ﬁxed quantity of a vaccine would result
n the largest reduction of the epidemic’s initial effective repro-
uctive number Re(0). For epidemics with the largest Re(0), school
ge children had the highest values of RR and vaccination of this
roup resulted in the largest reduction of the epidemics effective
eproductive number Re(0). We  note that this conclusion about the
accination of school-age children is consistent with results of pre-
ious work (Wallinga et al., 2010; Goldstein et al., 2010; Longini
t al., 2004; Ndeffo Mbah et al., 2013).
Our analysis is based on the assumption that higher values of
R estimated from the hospitalization data correspond to stronger
epletion of susceptibles. That depletion might have occurred both
ue to natural infections and vaccination. Compared to adults, chil-
ren had higher vaccination rates (CDC, 2013), and generally higher
accine effectiveness (Jackson et al., 2013b; MacIntosh et al., 2013),
nd one may  wonder to what extent the decline in the share of
hildren in incidence after the epidemic’s peak is explained by vac-
ination. We  note that for the 2009 season, the epidemic had largely
ubsided by the end of November (CDC, 2010). Vaccine coverage
evels at that point were quite modest, and vaccine coverage differ-
nces between children and non-elderly adults were even smaller
Singleton et al., 2010), suggesting a minor relative impact of vac-
ination on post-peak attack rates in children compared to adults.
or the other seasons during our study period for which data are
vailable, most vaccine administration took place by the end of
ovember (CDC, 2013), before the peak period in inﬂuenza activity
see http://www.cdc.gov/ﬂu/weekly/pastreports.htm, particularly
he Inﬂuenza-Like-Illness curves), with additional, more limited
evels of vaccine administration taking place in all age groups dur-
ng the winter. Thus comparison of the share of children among
ospitalizations before vs. after the epidemic peak largely refers to
wo time periods during which not many individuals were vacci-
ated; moreover there is no evidence in the data that during those
eriods of limited vaccine administration, children were specif-
cally overrepresented in coverage during the epidemics’ ascent
ompared to the descent. Altogether, vaccination alone is unlikely
o explain the high estimates of RR among 5–17 year-olds, partic-
larly for the largest epidemics in the data.
While there is a strong correspondence between an age group
ith the highest value of RR and the highest impact of vaccination
n Re(0), this correspondence was violated for certain simulated
pidemics with a medium-to-small Re(0). We  note that for all the
imulated epidemics with 5–17 year-olds either not having thecs 13 (2015) 10–16 15
highest RR or the largest impact on Re(0) through vaccination,
these children had a smaller relative susceptibility than one of the
other age groups. Our analyses suggest that the latter might be
relevant to inﬂuenza B epidemics, and possibly to the fairly size-
able 2013–2014 A/H1N1 outbreak during which children 0–4 had
very limited prior exposure and immunity to that virus. Additional
considerations, such as those based on the pre-seasonal collection
of serological data or information on previous circulation of certain
viruses might provide further insights into the relative roles of the
different age groups during future inﬂuenza outbreaks.
It is uncertain to what extent the proposed simulation
framework reﬂects the reality of inﬂuenza transmission in the com-
munity. Our primary aim in using these simulations was to examine
to what extent groups having the highest values of RR (that can
be found from the epidemic data) are also the groups for which
vaccination would have the largest impact on reducing the epi-
demic’s initial effective reproductive number Re(0). This issue was
assessed for a wide range of relative susceptibilities across the dif-
ferent age groups in an attempt to capture the spectrum of possible
scenarios for inﬂuenza transmission dynamics in the population.
The proposed framework might still not be able to capture the full
spectrum of those scenarios. For example, the group with the high-
est RR was children aged 5–17 in the vast majority of simulated
epidemics, and never adults aged 18–49. This does not agree with
the hospitalization data for inﬂuenza B epidemics, which may  be
affected by additional factors such cross-immunity from concur-
rent or immediately prior inﬂuenza A epidemics (Goldstein et al.,
2011) and initial susceptibilities in the different age groups lying
outside the range considered in our simulations. At the same time,
for the inﬂuenza A epidemics in the hospitalization data, RR was
highest for children aged 5–17 except for the very small, 2011–2012
A/H1N1 season, for which our estimate was  associated with con-
siderable uncertainty.
Our method has some additional limitations. Spatial hetero-
geneity could lead to variation in the local timing of the epidemic
peak across locations. We  note that such heterogeneity should bias
the estimates toward the null hypothesis (making the RR estimates
in different age groups closer to each other). There is some uncer-
tainty regarding the estimation of the hospitalization burden due
to particular subtypes of inﬂuenza A, given the presence of un-
subtyped cases, and the potential differences in the likelihood of an
inﬂuenza A infection being subtyped between A/H1N1 and A/H3N2
due to a possible spatial asynchrony in their circulation and differ-
ences in laboratory facilities. We note that the impact of the latter
on the dominant subtype estimates is minor if the dominant sub-
type’s circulation levels are signiﬁcantly higher than that of the
other subtype. Finally, while our inference does not require the
likelihood of a detection of a hospitalized inﬂuenza case to be con-
stant throughout each inﬂuenza season, we assume that it scales
with time in the same manner for all age groups. The latter assump-
tion may  be violated for an age group that has a sub-population with
both a different risk of infection and a different case-hospitalization
rate compared with the whole age group. We note that violation of
this assumption for a particular age group would have no impact
on the relative magnitude of RRs for other age groups.
5. Conclusions
Despite certain limitations, our results provide a cross-seasonal
comparison of the relative roles of different age groups during
epidemics associated with the major inﬂuenza (sub)types. Our
estimates and simulation results both exhibit the variability in
these relative roles during different inﬂuenza epidemics, and yield
consistent evidence for a leading role of school age children in
propagating the major inﬂuenza A epidemics.
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